2025 · 3rd Quarter (July 1 - Sep 30)

BIOGEN, INC.

Filed by FEDERAL STREET STRATEGIES, LLC.

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 21, 2025
Income: $50,000.00
Expenses: Not reported
Registrant: FEDERAL STREET STRATEGIES, LLC
Client: BIOGEN, INC.
Filing UUID: 426cc864-b0a9-43e1-8ec0-afbd290b783e
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Monitoring issues related to Alzheimer's Disease and treatment. Amyotrophic lateral sclerosis (ALS), Lou Gehrigs Disease and treatment. Monitor issues related to the FY2026 budget process

MMM · Medicare/Medicaid

Issues related to rare diseases and treatment. Issues related to Mental Health treatment. Issues related to maternal health. Monitor issues related to the FY2026 budget process

TAX · Taxation/Internal Revenue Code

Issues related to tax reform and the FY2026 budget process

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.